Biotech
HALIFAX, NOVA SCOTIA: Preliminary Analysis Supports the Ability of Immunovaccine's Lead Candidate to Induce T-Cell Infiltration Early Data Reflect Tolerability and Clinical Potential of the Triple Combination Immunoth ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 03/29/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TRIL) a clinical stage immuno-oncology company developing innovative therapies for the treatment of can ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 03/29/17 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, a ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 03/29/17 -- (NASDAQ: ATOS), today announced the pricing of an underwritten public offering with anticipated gross proceeds of $4,000,000, before deducting underwritin ...
ANN ARBOR, MI: Company Names New Board Member, Continues to Build Out Operations Team Through Appointment and Promotions ...
HALIFAX, NOVA SCOTIA: Study Designed to Assess Synergies of Combining DepoVax(TM)-based Cancer Vaccines and Novel Monoclonal Antibody Immunotherapies ...
LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 03/24/17 -- Tiziana Life Sciences PLC (AIM: TILS)AIM: TILS- Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology ...
TUSTIN, CA: TUSTIN, CA -- (Marketwired) -- 03/23/17 -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP), today announced that the company has be ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 03/22/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/21/17 -- Prevtec Microbia Inc. is pleased to announce that it received an investment from some of the Company's shareholders in the amount of CAD $2.5 mi ...
REDWOOD CITY, CA: New product protects against intracellular immune responses and exonuclease attack ...
ANN ARBOR, MI: Grant Funding Combined with Recent Financing Will Support Final IND-Enabling Studies for Novel Retinal Disease Drug Candidate ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/20/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the six months ended ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 03/20/17 --Trial did not meet primary endpoint (overall ADHD-RS), however showed encouraging trend in improvement at highest dose (400 mg BID)Strong trend of effic ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 03/17/17 -- ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring India Globalization Ca ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/16/17 -- Vinergy Resources Ltd. ("Vinergy" or the "Company")(CSE: VIN)(OTCQB: VNNYF) in conjunction with its proposed acquisiti ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 03/15/17 -- (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the Oppenheimer 27th Annual ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 03/14/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") announces that the second cohort comprising six patients ha ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/14/17 -- Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE: VIN)(CSE: VIN.CN)(OTCQB: VNNYF) in conjunction with its prop ...
